Biomarker analysis
tumor, AITL, PTCL, ALK-ALCL, PTCL-NOS, peripheral T-cell lymphoma, killer/T-cell lymphoma, ENKTL
PERIPHERAL T-CELL LYMPHOMA, TUMOR, ANAPLASTIC LARGE CELL LYMPHOMA, ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
Eight patients had available tumor biopsy samples for PD-L1 testing (PD-L1 immunohistochemistry staining of tumor biopsy samples from eight PTCL patients Outcomes of eight patients with PD-L1 expression result.AITL, angioimmunoblastic T-cell lymphoma; ALK-ALCL, ALK negative anaplastic large cell lymphoma; ENKTL, extra nodal natural killer/T-cell lymphoma; PTCL-NOS, peripheral T-cell lymphoma, not otherwise specified; PFS, progression-free survival.